495 642

Cited 0 times in

혈청 전립선특이항원 2.5-9.9ng/ml인 한국인에서 전립선암 유병률 추정

Other Titles
 Estimated Prostate Cancer Prevalence in Korean Men with Serum Prostate-specific Antigen 2.5-9.9ng/ml 
 조진선  ;  김선일  ;  홍성준  ;  임형준  ;  최영득  ;  정병하  ;  조인래  ;  조강수  ;  전상현  ;  양원재  ;  이동현  ;  송윤섭  ;  성도환  ;  김홍섭  ;  김천일  ;  김영식  ;  김세중 
 Korean Journal of Urological Oncology, Vol.5(3) : 144-147, 2007 
Journal Title
Korean Journal of Urological Oncology(대한비뇨기종양학술지)
Issue Date
Purpose: The aim of this study was to estimate the number of prevalent cases of biopsy detectable prostate cancer in Korean men with prostate-specific antigen(PSA) 2.5-9.9ng/ml. Materials and Methods: We analyzed 2,422 Korean men who had undergone prostate biopsy at 11 medical centers from 1993 to 2002. A total of 45,074 men(aged 50 to 79 years) carried out serum PSA level test at routine physical check-ups, between 1999 and 2005, at 12 domestic hospitals. We combined these results with published data from Korean population census in 2005, and calculated the prostate cancer prevalence in Korean men with PSA 2.5-9.9ng/ml. Results: There are estimated 94,900(1.9%) and 34,500(0.7%) prevalent cases of biopsy detectable prostate cancer in men aged 50-79 years with a serum PSA 2.5-9.9ng/ml and 4.0-9.9ng/ml, respectively. Conclusions: A large number of prevalent cases of biopsy detectable prostate cancer exist in Korean men with PSA 2.5-9.9ng/ml. This information is useful for patient counseling and provides strategy for PSA screening.
Files in This Item:
T200701494.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Chung, Byung Ha(정병하) ORCID logo https://orcid.org/0000-0001-9817-3660
Cho, Kang Su(조강수) ORCID logo https://orcid.org/0000-0002-3500-8833
Choi, Young Deuk(최영득) ORCID logo https://orcid.org/0000-0002-8545-5797
Hong, Sung Joon(홍성준) ORCID logo https://orcid.org/0000-0001-9869-065X
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.